Dermatology News Archives
Medication-related adverse events occur more frequently with methotrexate in children with moderate to severe psoriasis.
Physicians rate a high proportion of patients with atopic dermatitis as having inadequate disease control.
Body mass index is linked to malignant melanoma in men.
Oxybenzone, found in sunscreens and other products, has harmful dermatological and environmental effects.
Methotrexate treatment is associated with a significant improvement in symptoms of moderate to severe atopic dermatitis compared with cyclosporine treatment.
American Joint Commtitee on Cancer melamona staging system revised.
Patients with psoriasis whose disease affects >10% of their body surface area (BSA) are at an increased risk for death compared with the general population.
Discrepancies were observed in disclosure forms of industry payments received by authors of dermatology clinical practice guidelines.
Sleep complaints among individuals with psoriasis warrant greater clinical attention, as they have a greater chance for developing obstructive sleep apnea.
Patients with psoriasis have a greater risk of mortality due to alcohol-related causes, including alcoholic liver disease, fibrosis and cirrhosis of the liver, and mental and behavioral disorders.
This study shows that more than 50% of patients can expect a 90% or greater improvement in scalp psoriasis within 12 weeks.
Oral isotretinoin showed the best response in cases of facial warts
Researchers observed a positive correlation between the amount and duration of smoking and the occurrence of psoriasis.
Noninvasive test effective for monitoring hepatic fibrosis in psoriasis patients taking methotrexate
NASH FibroSure is useful to monitor for risk of worsening fibrosis during MTX therapy.
Biosimilar ABP 501 has similar clinical efficacy and safety to adalimumab for the treatment of plaque psoriasis.
The treatment is a promising, effective, and safe immunotherapeutic modality for common warts.
Dalazatide treatment reduced the plasma levels of multiple inflammation markers and reduced the expression of T cell activation markers on peripheral blood memory T cells.
The guidelines are the first to provide recommendations for comorbidity screening in pediatric psoriasis patients.
A rare case reports a 51-year-old man who primarily presented with multiple nodules on his scalp.
The risks of both stroke and myocardial infarction were highest the first year after the onset of herpes zoster and decreased with time.
Symptoms of an allergic reaction to an insect sting may include itching and hives, swelling in the throat or tongue, difficulty breathing, dizziness, stomach cramps, nausea, or diarrhea.
The most common comorbidities found in patients with psoriasis are hyperlipidemia, hypertension, depression, type 2 diabetes mellitus, and obesity.
Researchers sought to analyze long-term and real-world outcome data in patients with moderate-to-severe psoriasis after starting biologic treatment.
Antibiotics in conjunction with incision and drainage improved short-term outcomes compared with incision and drainage alone.
The number of emergency department visits for herpes zoster have increased from 2006 to 2013.
Treatment resulted in improvements in nail psoriasis vs placebo at 16 weeks.
Presence of psoriatic arthritis, weight, employment status, baseline disease severity affect the selection of first-line biologic treatment.
Participants in clinical studies who received Dupixent achieved clear or almost clear skin and a reduction in itch after 16 weeks of treatment.
The injected medication has been approved for use by patients who have failed to respond to other systemic therapies.
Patients exhibited a significant therapeutic response to immunotherapy compared with cryotherapy.
Participants underwent patch testing for food in an effort to examine whether food additives play a role in recurrent aphthous stomatitis etiology.
In a controlled trial, participants receiving Eucrisa achieved clear or almost clear skin after 28 days of treatment.
Phenotype-based treatments are recommended for presenting signs and symptoms of rosacea.
Over-the-counted remedies are not as effective as prescription medications.
Differin Gell 0.1% (adapalene) is the first retinoid approved for over-the-counter treatment of acne by the FDA.
Primary care screening can help patients avoid the need for more aggressive therapy and potentially save lives.
Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.
Overall quality of the studies reviewed was poor, leaving gaps in the development treatment recommendations for MC.
Approximately a quarter of patients with infantile hemangioma experience rebound growth, which happens at a mean age of 17.1 months.
A new blood test assesses levels of circulating tumor DNA (ctDNA) in patients with unresectable stage IIIC/IV melanoma.
The USPTF has determined that there is insufficient evidence for the harms and benefits of visual skin cancer screening.
Escalating prices were found across all categories of dermatologic drugs, including anti-infective medications and treatments for psoriasis and rosacea.
El Nino and La Nina have been linked to increases in actinic keratosis, rosacea, dermatitis, psoriasis, and varicella, among other dermatologic conditions.
Two studies indicate that brodalumab and secukinumab had significant benefits for patients with psoriasis or psoriatic arthritis.
Researchers found a significant link between moderate to severe rosacea and many comorbid conditions.
Patients with psoriasis, especially those with psoriatic arthritis, have an increased risk of arrhythmia.
A non-invasive laser test can accurately identify melanoma with 100% accuracy.
Many moles increases melanoma risk, but fewer moles are linked to more aggressive forms of melanoma.
Combination therapy of glycolic acid peels and iontophoresis with vitamins A, C, and E effectively treats acne.
The FDA has approved Finacea Foam for the topical treatment of rosacea.
Women with psoriasis and psoriatic arthritis have an increased risk of depression.
Clinicians should warn patients about the dangers of sunburn and discourage this new trend.
Psoriasis patients exposed to trauma have an increased risk for psoriatic arthritis.
The monoclonal antibody ixekizumab was more effective than other treatments for treating psoriasis.
Guselkumab was more effective than standard psoriasis treatment but had higher rates of pneumonia.
Patients with alopecia areata have lower serum zinc levels compared with controls.
People with newly diagnosed psoriatic arthritis have an increased risk of later CVD.
Janus kinase inhibitors are indicated for rheumatoid arthritis, but they may be able to treat vitiligo.
Most patients who were initially diagnosed with cellulitis were diagnosed with pseudocellulitis in inpatient settings.
Nearly 20% of patients lost more than 5% of their baseline weight by 52 weeks or less when assigned to receive apremilast.
Patients with psoriasis should avoid long-term use of medications that are toxic to the kidneys.
Patient with psoriasis were unsuccessfully treated with conventional therapies before treatment with biologics.
Patients with psoriasis do not have an increased of major cardiovascular events like heart attack and stroke.
Patients taking adalimumab saw quicker treatment of their psoriasis than those taking methotrexate.
While women accounted for 57% of melanomas reported between 1973 and 1980, they comprised about 65% of all diagnoses by 2011.
A study suggests that clindamycin and TMP-SMX are equally effective for treating uncomplicated skin infections in adults and children.
Male patients with psoriasis have higher levels of estradiol and lower levels of testosterone compared with controls.
The homeostasis model assessment of insulin resistance index did not differ significantly for patients with post-adolescent acne and controls.
After adjustment for known risk factors, increased relative risk for women with history of acne.
The rate of reported adverse events was comparable in both the treatment and placebo groups.
The preferred order for combining a second modality with biologics is biologic and methotrexate combination, biologic and acitretin combination, and then biologic and phototherapy combination.
These study findings confirm that the therapeutic silencing of IL-23 is a potential target for psoriasis prevention and management.
Consistent evidence supports the use of fish oil supplementation. Zinc supplementation, however, has not been proven effective.
Of the patients, 38% (n=134) reported current genital involvement while 64% (n=224) had a current and/or previous history of genital involvement.
The presence of snoring was not associated with a higher risk of psoriasis.
This discovery could prevent progression of psoriatic arthritis in patients with psoriasis.
Infliximab and ustekinumab 90 mg were the most costly therapies.
The 31 patients who received BI 655066 had clinical improvement beginning at week 2 and maintained through week 66 weeks.
The prevalence of H. pylori was not higher in psoriasis versus the control, but patients infected with H. pylori showed more severe psoriasis compared with uninfected patients.
Long-term use of medications such as acetaminophen, ibuprofen, and aspirin may double a patient's risk of developing psoriatic arthritis.
Providers may have not made changes to treatment strategies due to the high effectiveness of biologics in most visits.
The proposed model has been presented to the World Health Organization groups in charge of International Classification of Diseases (ICD-11) revision.
Adults with eczema had $371 to $489 higher out-of-pocket costs per person-year compared with those without the disease.
The coexistence of psoriasis with lupus erythematosus is rare and often presents a therapeutic challenge.
Human breast milk can improve infant atopic eczema with the same results as 1% hydrocortisone ointment, according to researchers.
The initial site of articular inflammation is where the Achilles tendon attaches to the bone.
The long-term safety profile of continuous fumaric acid esters treatment is favorable.
Less likely to engage in moderate to vigorous physical activity, especially those with severe disease
The causative link between chronic tonsillitis and psoriasis have been mostly speculative based on translational association studies.
Secukinumab has been approved by the FDA for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.
People who drank one to three cups a day had about a 10% decreased risk of melanoma compared with those who drank none at all.
Among women with a history of severe teenage acne, the relative risk increased for melanoma even after adjustment for previously known risk factors.
Educational programs may improve cardiovascular and metabolic risk management in patients.
Agents in biologic monotherapy target key processes in the pathogenesis of psoriasis, therefore offering better efficacy than current biologic and systemic therapies.
Direct costs of psoriasis ranged from $51.7 billion to $63.2 billion, and indirect costs ranged from $23.9 billion to $35.4 billion.
Clinicians who treat patients with psoriasis may need additional training in lifestyle behavior modification initiatives.
Overweight and obese psoriasis patients should to lose weight and increase physical activity as a way to improve psoriasis symptoms.
Dalvance is used to treat acute bacterial skin and skin structure infections (ABSSSI) that have been caused by certain susceptible Gram-positive organisms.
The increased risk of CKD and GN was seen in patients with both mild and severe psoriasis.
The decreasing popularity of tanning salons may be a contributing factor to the drop of emergency care visits because of overexposure to UV radiation.